BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 15650202)

  • 1. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
    Strain MC; Letendre S; Pillai SK; Russell T; Ignacio CC; Günthard HF; Good B; Smith DM; Wolinsky SM; Furtado M; Marquie-Beck J; Durelle J; Grant I; Richman DD; Marcotte T; McCutchan JA; Ellis RJ; Wong JK
    J Virol; 2005 Feb; 79(3):1772-88. PubMed ID: 15650202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic attributes of cerebrospinal fluid-derived HIV-1 env.
    Pillai SK; Pond SL; Liu Y; Good BM; Strain MC; Ellis RJ; Letendre S; Smith DM; Günthard HF; Grant I; Marcotte TD; McCutchan JA; Richman DD; Wong JK
    Brain; 2006 Jul; 129(Pt 7):1872-83. PubMed ID: 16735456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function.
    Vecchi M; Burighel N; Bellanova D; Menzo S; De Rossi A; Clementi M; Bagnarelli P
    New Microbiol; 2004 Apr; 27(2 Suppl 1):99-104. PubMed ID: 15646071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1.
    Kupfer B; Sing T; Schüffler P; Hall R; Kurz R; McKeown A; Schneweis KE; Eberl W; Oldenburg J; Brackmann HH; Rockstroh JK; Spengler U; Däumer MP; Kaiser R; Lengauer T; Matz B
    J Med Virol; 2007 Nov; 79(11):1629-39. PubMed ID: 17854039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies.
    Ibáñez A; Clotet B; Martínez MA
    J Gen Virol; 2000 Jan; 81(Pt 1):85-95. PubMed ID: 10640545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic shift of env V3 loop viral sequences in patients with HIV-associated neurocognitive disorder during antiretroviral therapy.
    Eggers C; Müller O; Thordsen I; Schreiber M; Methner A
    J Neurovirol; 2013 Dec; 19(6):523-30. PubMed ID: 24101298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant genotypic resistance and HIV-1 genetic diversity from paired plasma and cerebrospinal fluid samples in Chinese settings.
    Liu L; Zhang Y; Wei F; Zhao Q; Wang X; Yuan L; Li N; Chen D
    J Neurovirol; 2013 Apr; 19(2):131-6. PubMed ID: 23325676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.
    Kijak GH; Simon V; Balfe P; Vanderhoeven J; Pampuro SE; Zala C; Ochoa C; Cahn P; Markowitz M; Salomon H
    J Virol; 2002 Jul; 76(14):7000-9. PubMed ID: 12072500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HIV-1 pol and env sequences of blood, CSF, brain and spleen isolates collected ante-mortem and post-mortem.
    Caragounis EC; Gisslén M; Lindh M; Nordborg C; Westergren S; Hagberg L; Svennerholm B
    Acta Neurol Scand; 2008 Feb; 117(2):108-16. PubMed ID: 18184346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity of human immunodeficiency virus type 1 strains in Kinshasa, Zaire.
    Potts KE; Kalish ML; Bandea CI; Orloff GM; St Louis M; Brown C; Malanda N; Kavuka M; Schochetman G; Ou CY
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):613-8. PubMed ID: 8369166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV encephalitis in a patient on antiretroviral therapy: a case report.
    Hlebowicz M; Parczewski M; Jakubowski P
    Int J STD AIDS; 2019 May; 30(6):617-619. PubMed ID: 30722753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1.
    Ritola K; Pilcher CD; Fiscus SA; Hoffman NG; Nelson JA; Kitrinos KM; Hicks CB; Eron JJ; Swanstrom R
    J Virol; 2004 Oct; 78(20):11208-18. PubMed ID: 15452240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar.
    Motomura K; Kusagawa S; Kato K; Nohtomi K; Lwin HH; Tun KM; Thwe M; Oo KY; Lwin S; Kyaw O; Zaw M; Nagai Y; Takebe Y
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1831-43. PubMed ID: 11118069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.